Inflammatory Biomarkers Aid in Diagnosis of Dementia

Inflammatory Biomarkers Aid in Diagnosis of Dementia

Dual pathology of Alzheimer's disease (AD) and vascular cognitive impairment and dementia (VCID) commonly are found together at autopsy, but mixed dementia (MX) is difficult to diagnose during life. Biological criteria to diagnose AD have been defined, but are not available for vascular disease...

Full description

Bibliographic Details
Main Authors:	Erik B. Erhardt, John C. Adair, Janice E. Knoefel, Arvind Caprihan, Jillian Prestopnik, Jeffrey Thompson, Sasha Hobson, David Siegel, Gary A. Rosenberg
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-08-01
Series:	Frontiers in Aging Neuroscience
Subjects:	Alzheimer's disease vascular cognitive impairment and dementia inflammation diffusion tensor imaging cerebrospinal fluid white matter disease
Online Access:	https://www.frontiersin.org/articles/10.3389/fnagi.2021.717344/full

Similar Items

A Multimodal Approach to Stratification of Patients with Dementia: Selection of Mixed Dementia Patients Prior to Autopsy
by: Gary A. Rosenberg, et al.
Published: (2019-08-01)

Screening for New Biomarkers for Subcortical Vascular Dementia and Alzheimer’s Disease
by: Annika Öhrfelt, et al.
Published: (2011-01-01)

A selenium species in cerebrospinal fluid predicts conversion to Alzheimer’s dementia in persons with mild cognitive impairment
by: Marco Vinceti, et al.
Published: (2017-12-01)

Qualitative Assessment of Longitudinal Changes in Phenocopy Frontotemporal Dementia
by: Rozanna Meijboom, et al.
Published: (2019-11-01)

Correlation between CSF biomarkers of Alzheimer’s disease and global cognition in a psychogeriatric clinic cohort
by: Márcia Radanovic, et al.

Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid
by: Anna Rosenberg, et al.
Published: (2019-12-01)

Cerebrospinal fluid P-tau181P: biomarker for improved differential dementia diagnosis
by: Hanne eStruyfs, et al.
Published: (2015-06-01)

Identifying amyloid pathology–related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study
by: Yuk Yee Leung, et al.
Published: (2015-09-01)

The dementia and disability project in Thai elderly: rational, design, methodology and early results
by: Senanarong Vorapun, et al.
Published: (2013-01-01)

Dementia and Impairment, Directions for no specialist physicians
by: Archibaldo Donoso
Published: (2007-11-01)

Dementia with Parkinson's disease: Clinical diagnosis, neuropsychological aspects and treatment
by: Jorge Lorenzo Otero

Comparing Cerebral White Matter Lesion Burdens between Parkinson’s Disease with and without Dementia
by: Sun-Ah Choi, et al.
Published: (2010-05-01)

Mild behavioral impairment: A prodromal stage of dementia
by: Fernando E. Taragano, et al.

Brain Network Integrity Changes in Subjective Cognitive Decline: A Possible Physiological Biomarker of Dementia
by: Hilla Fogel, et al.
Published: (2021-08-01)

Impact of Hypertension on Cognitive Decline and Dementia
by: Han Lin Naing, et al.
Published: (2020-03-01)

Cognitive impairment and dementia in Parkinson's disease
by: Javier Pagonabarraga, et al.
Published: (2012-06-01)

Accumulation of Cerebrospinal Fluid Glycerophospholipids and Sphingolipids in Cognitively Healthy Participants With Alzheimer’s Biomarkers Precedes Lipolysis in the Dementia Stage
by: Alfred N. Fonteh, et al.
Published: (2020-12-01)

Dementia: epidemiology, clinical picture, diagnosis, approaches to therapy
by: Irina Sergeyevna Preobrazhenskaya
Published: (2013-12-01)

Tau Pathology and Parietal White Matter Lesions Have Independent but Synergistic Effects on Early Development of Alzheimer's Disease
by: Joakim Hertze, et al.
Published: (2013-04-01)

Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer’s disease
by: Inês Baldeiras, et al.
Published: (2019-01-01)

Deciphering the factors that influence participation in studies requiring serial lumbar punctures
by: Gregory S. Day, et al.
Published: (2020-01-01)

Quantitative balance and gait measurement in patients with frontotemporal dementia and Alzheimer diseases: A pilot study
by: Selva Ganapathy Velayutham, et al.
Published: (2017-01-01)

Recent Updates on Subcortical Ischemic Vascular Dementia
by: Jee Hoon Roh, et al.
Published: (2014-01-01)

Experiences of dementia and attitude towards prevention: a qualitative study among older adults participating in a prevention trial
by: Anna Rosenberg, et al.
Published: (2020-03-01)

Chronic kidney disease and vascular dementia
by: N A Mukhin, et al.
Published: (2014-06-01)

The borderland between normal aging and dementia
by: Raymond Y Lo
Published: (2017-01-01)

Mild cognitive impairment (part 1): clinical characteristics and predictors of dementia
by: Orestes V. Forlenza, et al.
Published: (2013-06-01)

Depressive symptoms and CSF Alzheimer's disease biomarkers in relation to clinical symptom onset of mild cognitive impairment
by: Carol K. Chan, et al.
Published: (2020-01-01)

Structural connectivity is differently altered in dementia with Lewy Body and Alzheimer’s Disease
by: Stefano eDelli Pizzi, et al.
Published: (2015-11-01)

Retracted: The Increasing Risk of Dementia in Psoriasis: A Systematic Review and Meta-Analysis
by: Chayada Chaiyabutr, et al.
Published: (2021-02-01)

Differential diagnostic value of total alpha-synuclein assay in the cerebrospinal fluid between Alzheimer’s disease and dementia with Lewy bodies from the prodromal stage
by: Olivier Bousiges, et al.
Published: (2020-09-01)

An overview of systematic reviews of ginkgo biloba and its extracts for mild cognitive impairment and dementia
by: Guo-qing Zheng, et al.
Published: (2016-12-01)

Cognitive impairment and dementia
by: V. A. Parfenov, et al.
Published: (2018-11-01)

The Use of Biomarkers and Genetic Screening to Diagnose Frontotemporal Dementia: Evidence and Clinical Implications
by: Helena Gossye, et al.
Published: (2019-08-01)

Imaging Mild Cognitive Impairment and Dementia in Parkinson's Disease
by: Sanskriti Sasikumar, et al.
Published: (2020-01-01)

Depression and dementia: differentiation and comorbidity
by: V. Yu. Lobzin, et al.
Published: (2020-08-01)

Pain management in patients with dementia
by: Achterberg WP, et al.
Published: (2013-11-01)

Cognitive impairment and dementia – an update
by: João eMassano, et al.
Published: (2012-10-01)

Neurofilaments and tau proteins in cerebrospinal fluid and serum in dementias and neuroinflammation
by: Lenka Fialova, et al.
Published: (2017-09-01)

Remote cognitive and behavioral assessment: Report of the Alzheimer Society of Canada Task Force on dementia care best practices for COVID‐19
by: Maiya R. Geddes, et al.
Published: (2020-01-01)